BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 14135439)

  • 1. ANTISEROTONIN ACTION OF LSD-25 AND OTHER LYSERGIC ACID DERIVATIVES: FACT AND FICTION.
    ABRAMSON HA
    J Asthma Res; 1964 Mar; 1(3):207-11. PubMed ID: 14135439
    [No Abstract]   [Full Text] [Related]  

  • 2. LYSERGIC ACID DIETHYL AMIDE (LSD-25): XXXVII. ANTISEROTONIN ACTION OF LYSERGIC ACID DERIVATIVES IN ALLERGY AND NEUROPSYCHIATRY.
    ABRAMSON HA
    J Asthma Res; 1965 Mar; 2(3):257-62. PubMed ID: 14285481
    [No Abstract]   [Full Text] [Related]  

  • 3. [EFFECT OF SOME ANTISEROTONIN DRUGS ON BLOOD COAGULATION].
    BADYDA C; BIELSKI J; CHODERA A; OWCZAREK L
    Acta Physiol Pol; 1963; 14():645-52. PubMed ID: 14123361
    [No Abstract]   [Full Text] [Related]  

  • 4. THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
    CROWTHER DL
    Med Exp Int J Exp Med; 1964; 10():137-43. PubMed ID: 14129849
    [No Abstract]   [Full Text] [Related]  

  • 5. COMPARATIVE STUDY OF ANTISEROTONIN EFFECTS OF LYSENYL AND DESERIL.
    RYSANEK K; VITEK V
    Gastroenterologia; 1964; 102():1-10. PubMed ID: 14187206
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON THE ANTISEROTONIN EFFECT OF THE 1-METHYL DERIVATIVE OF LYSERGIC ACID ON THE CHORIORETINAL VESSELS OF THE PREGNANT RABBIT].
    MORLUNGHI C; VOLPI U
    Ann Ottalmol Clin Ocul; 1964 May; 90():260-4. PubMed ID: 14199012
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.
    SICUTERI F
    Med Exp Int J Exp Med; 1960; 2():36-9. PubMed ID: 14446407
    [No Abstract]   [Full Text] [Related]  

  • 8. Actions of derivatives of lysergic acid on the heart of Venus mercenaria.
    WRIGHT AM; MOCRHEAD M; WELSH JH
    Br J Pharmacol Chemother; 1962 Apr; 18(2):440-50. PubMed ID: 14008412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of autistic schizophrenic children with LSD-25 and UML-491.
    BENDER L; GOLDSCHMIDT L; SANKAR DV
    Recent Adv Biol Psychiatry; 1961; 4():170-9. PubMed ID: 13867084
    [No Abstract]   [Full Text] [Related]  

  • 10. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HISTOCHEMICAL STUDIES ON THE MECHANISM OF ACTION OF THE HALLUCINOGENS D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (LSD-25) AND D-2-BROMO-LYSERGIC ACID TARTRATE (BOL-148) IN RAT BRAIN.
    SHANTHAVEERAPPA TR; NANDY K; BOURNE GH
    Acta Neuropathol; 1963 Sep; 3():29-39. PubMed ID: 14197655
    [No Abstract]   [Full Text] [Related]  

  • 12. [INTRAVASCULAR ERYTHROCYTE AGGREGATION AND D-1 METHYL-LYSERGIC ACID BUTANOLAMIDE (DESERRIL OR UML 491)].
    PIOVELLA C; DESILVESTRI A
    Cuore Circ; 1963 Aug; 47():179-85. PubMed ID: 14084723
    [No Abstract]   [Full Text] [Related]  

  • 13. ANTIMESCALINE PROPERTIES OF SOME LYSERGIC ACID DERIVATIVES.
    BORSY J; HUSZTI Z; FEKETE M
    Int J Neuropharmacol; 1963 Dec; 2():273-7. PubMed ID: 14119487
    [No Abstract]   [Full Text] [Related]  

  • 14. PROPHYLACTIC TREATMENT OF MIGRAINE BY MEANS OF LYSERGIC ACID DERIVATIVES.
    SICUTERI F
    Triangle; 1963 Oct; 6():116-25. PubMed ID: 14087164
    [No Abstract]   [Full Text] [Related]  

  • 15. METHYSERGIDE IN THE PROPHYLAXIS OF MIGRAINE.
    SOUTHWELL N; WILLIAMS JD; MACKENZIE I
    Lancet; 1964 Mar; 1(7332):523-4. PubMed ID: 14100184
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical and rheographic considerations on a new antiserotonin derivative (UML-491) with preventive action in hemicrania].
    REBUCCI GG; COCCAGNA G
    Riv Neurol; 1962; 32():574-85. PubMed ID: 13973457
    [No Abstract]   [Full Text] [Related]  

  • 17. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
    FRIEDMAN AP; LOSIN S
    Arch Neurol; 1961 Mar; 4():241-5. PubMed ID: 13701987
    [No Abstract]   [Full Text] [Related]  

  • 19. [SEROTONIN AND PSYCHIATRY].
    PELICIER Y
    Pathol Biol; 1964 Nov; 12():1107-9. PubMed ID: 14224288
    [No Abstract]   [Full Text] [Related]  

  • 20. [EFFECT OF THE SEROTONIN ANTAGONIST DESERIL (1-METHYL-LYSERGIC ACID BUTANOLAMIDE) ON THE TOTAL CATECHOLAMINE LEVEL IN WHOLE BLOOD AND ITS ROLE IN THE CARCINOID SYNDROME (CASSIDY-SCHOLTE)].
    UNGHVARY L; HOVANYI M; GOERGENYI F; FARKAS F
    Z Kreislaufforsch; 1963 Nov; 52():1125-8. PubMed ID: 14097993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.